Journal of Cancer Therapy

Vol.3 No.2(2012), Paper ID 18675, 5 pages

DOI:10.4236/jct.2012.32021

 

The Use of Neupogen (Filgrastim) or Neulasta (Pegfilgrastim) during Pregnancy When Chemotherapy Is Indicated for Maternal Cancer Treatment

 

Elyce Cardonick, Farhana Irfan, Natalie Torres

 

Cooper University Hospital, Cooper Medical School at Rowan, Camden, USA
Cooper University Hospital, Cooper Medical School at Rowan, Camden, USA.
Cooper University Hospital, Cooper Medical School at Rowan, Camden, USA

 

Copyright © 2012 Elyce Cardonick, Farhana Irfan, Natalie Torres et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


E. Cardonick, F. Irfan and N. Torres, "The Use of Neupogen (Filgrastim) or Neulasta (Pegfilgrastim) during Pregnancy When Chemotherapy Is Indicated for Maternal Cancer Treatment," Journal of Cancer Therapy, Vol. 3 No. 2, 2012, pp. 157-161. doi: 10.4236/jct.2012.32021.

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.